22 assets in Chronic Obstructive Pulmonary Disease

Therapeutic assets addressing Chronic Obstructive Pulmonary Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
20-valent pneumococcal conjugate vaccine Chronic Obstructive Pulmonary Disease	University of Alabama at Birmingham	P4	BB (65)
.Alpha.-1 Protease Inhibitor Chronic Obstructive Pulmonary Disease	Takeda	P4	BB (65)
Rymphysia Chronic Obstructive Pulmonary Disease	Takeda	P4	B (60)
Umeclidinium Chronic Obstructive Pulmonary Disease	Samsung Medical Center	P3	B (60)
Vilanterol Chronic Obstructive Pulmonary Disease	Samsung Medical Center	P3	B (60)
Teonanacatl Chronic Obstructive Pulmonary Disease	University Medical Center Groningen	P2	CCC (53)
XENON Chronic Obstructive Pulmonary Disease	University of Kansas Medical Center	P1	CCC (50)
Alemtuzumab Chronic Obstructive Pulmonary Disease	Paul Szabolcs	P1/2	CCC (48)
cd3/cd19 negative allogeneic hematopoietic stem cells Chronic Obstructive Pulmonary Disease	Paul Szabolcs	P1/2	CCC (48)
Fludarabine Chronic Obstructive Pulmonary Disease	Paul Szabolcs	P1/2	CCC (48)
Hydroxyurea Chronic Obstructive Pulmonary Disease	Paul Szabolcs	P1/2	CCC (48)
Rituximab Chronic Obstructive Pulmonary Disease	Paul Szabolcs	P1/2	CCC (48)
Semaglutide Chronic Obstructive Pulmonary Disease	University of Pennsylvania	P1/2	CCC (48)
Thiotepa Chronic Obstructive Pulmonary Disease	Paul Szabolcs	P1/2	CCC (48)
chf6001 dry powder inhaler Chronic Obstructive Pulmonary Disease	Chiesi Farmaceutici S.p.A.	P1	CC (47)
Cyclosporin A Chronic Obstructive Pulmonary Disease	Chiesi Farmaceutici S.p.A.	P1	CC (47)
Tanimilast Chronic Obstructive Pulmonary Disease	Chiesi Farmaceutici S.p.A.	P1	CC (47)
Gdc-6988 Chronic Obstructive Pulmonary Disease	Genentech, Inc.	P1	CC (43)
Montanide Isa 51 Chronic Obstructive Pulmonary Disease	Roswell Park Cancer Institute	Early P1	CC (43)
Recombinant Human Egf-Rp64K Chronic Obstructive Pulmonary Disease	Roswell Park Cancer Institute	Early P1	CC (43)
Dexmedetomidine Chronic Obstructive Pulmonary Disease	Tanta University	N/A	D (30)
Prednisolone Chronic Obstructive Pulmonary Disease	Karolinska Institutet	N/A	D (30)